Animal Study Identifies Potential Treatment For Huntington’s Disease
Oct 20th 2007Drug InformationHuntingtons Disease
MassGeneral Institute for Neurodegererative Disease (MIND) researchers have identified a compound that may lead to a treatment that could protect against the effects of Huntington’s Disease (HD). Their report, which will appear in the Proceedings of the National Academy of Sciences, describes how a small molecule called C2-8 appears to delay the loss of motor control and reduce neurological damage in a mouse model of the disorder. The study is receiving early online release. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
